The Oncosearch | Oncotarget

Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes Research Paper

Tomas Tokar, Chiara Pastrello, Varune R. Ramnarine, Chang-Qi Zhu, Kenneth J. Craddock, Larrisa A. Pikor, Emily A. Vucic, Simon Vary, Frances A. Shepherd, Ming-Sound Tsao, Wan L. Lam, Igor Jurisica

Published Jan 8, 2018 · Vol. 9, No. 10 · pp. 9137-9155

A comparative study of chemotherapy combined with intermittent microwave ablation and chemotherapy in the treatment of oligometastatic non-small cell lung cancer Research Paper

Linjia Zhu, Shaofei Yuan, Meizhen Liang, Youyi Wu

Published Jan 5, 2018 · Vol. 5

Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis Meta-Analysis

Bo Lan, Chengxi Ma, Chengyan Zhang, Shoujie Chai, Pingli Wang, Liren Ding, Kai Wang

Published Jan 5, 2018 · Vol. 9, No. 7 · pp. 7684-7699

Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer Research Paper

Mengyao Sun, Yang Bai, Song Zhao, Xiyu Liu, Yongsheng Gao, Lei Wang, Bin Liu, Dashi Ma, Chunye Ma

Published Jan 4, 2018 · Vol. 9, No. 17 · pp. 13462-13473

Long non-coding RNAs function as novel predictors and targets of non-small cell lung cancer: a systematic review and meta-analysis Meta-Analysis

Yanlu Xiong, Tao Wang, Mingxing Wang, Jinbo Zhao, Xiaofei Li, Zhipei Zhang, Yongsheng Zhou, Jiabao Liu, Lintao Jia, Yong Han

Published Jan 4, 2018 · Vol. 9, No. 13 · pp. 11377-11386

A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer Clinical Research Papers

Chenxue Jiang, Shuiyun Han, Wucheng Chen, Xiaozhen Ying, He Wu, Yaoyao Zhu, Guodong Shi, Xiaojiang Sun, Yaping Xu

Published Jan 3, 2018 · Vol. 9, No. 15 · pp. 12443-12451

TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway Research Paper

Sampa Ghoshal-Gupta, Ammar Kutiyanawalla, Byung Rho Lee, Juhi Ojha, Aliya Nurani, Ashis K. Mondal, Ravindra Kolhe, Amyn M. Rojiani, Mumtaz V. Rojiani

Published Jan 2, 2018 · Vol. 9, No. 10 · pp. 8941-8956

Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study) Research Paper

Romain Corre, Radj Gervais, Florian Guisier, Louis Tassy, Florent Vinas, RÃ©gine Lamy, Gislaine Fraboulet, Laurent Greillier, Helene Doubre, Renaud Descourt, Christos Chouaid, Jean-Bernard Auliac

Published Jan 2, 2018 · Vol. 9, No. 9 · pp. 8253-8262

Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples Research Paper

Ross A Soo, Joey Sze Yun Lim, Bernadette Reyna Asuncion, Zul Fazreen, Maria Cynthia Herrera, Mohd Feroz Mohd Omar, Nguyen Hoang Diem Phuong, Ju Ee Seet, Benhur Amanuel, Barry Iacopetta, David Byrne, Shona Hendry, Stephen Fox, Richie Soong

Published Jan 2, 2018 · Vol. 9, No. 6 · pp. 6841-6851

Cysts mark the early stage of metastatic tumor development in non-small cell lung cancer Research Paper

Chitra Thakur, Ulf R. Rapp, Thomas Rudel

Published Dec 30, 2017 · Vol. 9, No. 5 · pp. 6518-6535

The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells Research Paper

Sanchareeka Dey, Sharda Kumari, Sarada Preeta Kalainayakan, James Campbell III, Poorva Ghosh, Heling Zhou, Keely E. FitzGerald, Maoping Li, Ralph P. Mason, Li Zhang, Li Liu

Published Dec 28, 2017 · Vol. 9, No. 3 · pp. 4090-4101

The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages Research Paper

Yingcheng Wu, Qianqian Ju, Bei Qian, Feng Zhang, Hui Shi

Published Dec 26, 2017 · Vol. 9, No. 8 · pp. 7942-7948

Newly developed anti-angiogenic therapy in non-small cell lung cancer Review

Jingjing Qu, Yongchang Zhang, Xue Chen, Haiyan Yang, Chunhua Zhou, Nong Yang

Published Dec 26, 2017 · Vol. 9, No. 11 · pp. 10147-10163

Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis Meta-Analysis

Ramon Andrade De Mello, Carles Escriu, Pedro Castelo-Branco, Paloma Lucena Cabral, Giannis Mountzios, Gilberto de Lima Lopes, Pedro Madureira

Published Dec 23, 2017 · Vol. 9, No. 14 · pp. 11805-11815

Apatinib as a third- or further- line treatment in patients with advanced NSCLC harboring wild-type EGFR Clinical Research Papers

Shencun Fang, Meiling Zhang, Guihong Wei, Kai-Hua Lu

Published Dec 22, 2017 · Vol. 9, No. 6 · pp. 7175-7181

Implications of KRAS mutations in acquired resistance to treatment in NSCLC Review

Marzia Del Re, Eleonora Rofi, Giuliana Restante, Stefania Crucitta, Elena Arrigoni, Stefano Fogli, Massimo Di Maio, Iacopo Petrini, Romano Danesi

Published Dec 21, 2017 · Vol. 9, No. 5 · pp. 6630-6643

Anti-PD-1/PD-L1 antibodies versus docetaxel in patients with previously treated non-small-cell lung cancer Meta-Analysis

Qi Jiang, Mixue Xie, Mengye He, Feifei Yan, Xiaochen Zhang, Sufen Yu

Published Dec 21, 2017 · Vol. 9, No. 7 · pp. 7672-7683

Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer Research Paper

Jianchun Duan, Xiaodan Yang, Jun Zhao, Minglei Zhuo, Zhijie Wang, Tongtong An, Hua Bai, Jie Wang

Published Dec 20, 2017 · Vol. 9, No. 2 · pp. 2660-2667

Downregulation of long non-coding RNA LET predicts poor prognosis and increases Notch signaling in non-small cell lung cancer Research Paper

Shengwen Li, Hui Zhao, Jianqiang Li, Aizheng Zhang, Haibin Wang

Published Dec 19, 2017 · Vol. 9, No. 1 · pp. 1156-1168

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape Research Paper

Francisco Perea, Abel SÃ¡nchez-Palencia, Mercedes GÃ³mez-Morales, MÃ³nica Bernal, Ãngel Concha, MÃguela MÃ©ndez GarcÃa, Amanda RocÃo GonzÃ¡lez-RamÃrez, Martin Kerick, Javier Martin, Federico Garrido, Francisco Ruiz-Cabello, Natalia Aptsiauri

Published Dec 19, 2017 · Vol. 9, No. 3 · pp. 4120-4133

Publication Alerts

European Cancer and Oncology Congress

Post-Publication Promotion

Search Oncotarget

Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes Research Paper

A comparative study of chemotherapy combined with intermittent microwave ablation and chemotherapy in the treatment of oligometastatic non-small cell lung cancer Research Paper

Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis Meta-Analysis

Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer Research Paper

Long non-coding RNAs function as novel predictors and targets of non-small cell lung cancer: a systematic review and meta-analysis Meta-Analysis

A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer Clinical Research Papers

TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway Research Paper

Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study) Research Paper

Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples Research Paper

Cysts mark the early stage of metastatic tumor development in non-small cell lung cancer Research Paper

The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells Research Paper

The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages Research Paper

Newly developed anti-angiogenic therapy in non-small cell lung cancer Review

Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis Meta-Analysis

Apatinib as a third- or further- line treatment in patients with advanced NSCLC harboring wild-type EGFR Clinical Research Papers

Implications of KRAS mutations in acquired resistance to treatment in NSCLC Review

Anti-PD-1/PD-L1 antibodies versus docetaxel in patients with previously treated non-small-cell lung cancer Meta-Analysis

Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer Research Paper

Downregulation of long non-coding RNA LET predicts poor prognosis and increases Notch signaling in non-small cell lung cancer Research Paper

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape Research Paper

Publication Alerts

European Cancer and Oncology Congress

Oncoscience

Post-Publication Promotion

Search Oncotarget

Differentially expressed microRNAs in lung adenocarcinoma invert effects of copy number aberrations of prognostic genes Research Paper

A comparative study of chemotherapy combined with intermittent microwave ablation and chemotherapy in the treatment of oligometastatic non-small cell lung cancer Research Paper

Association between PD-L1 expression and driver gene status in non-small-cell lung cancer: a meta-analysis Meta-Analysis

Gram-negative bacteria facilitate tumor progression through TLR4/IL-33 pathway in patients with non-small-cell lung cancer Research Paper

Long non-coding RNAs function as novel predictors and targets of non-small cell lung cancer: a systematic review and meta-analysis Meta-Analysis

A retrospective study of shrinking field radiation therapy during chemoradiotherapy in stage III non-small cell lung cancer Clinical Research Papers

TIMP-1 downregulation modulates miR-125a-5p expression and triggers the apoptotic pathway Research Paper

Octogenarians with EGFR-mutated non-small cell lung cancer treated by tyrosine-kinase inhibitor: a multicentric real-world study assessing tolerance and efficacy (OCTOMUT study) Research Paper

Determinants of variability of five programmed death ligand-1 immunohistochemistry assays in non-small cell lung cancer samples Research Paper

Cysts mark the early stage of metastatic tumor development in non-small cell lung cancer Research Paper

The vascular disrupting agent combretastatin A-4 phosphate causes prolonged elevation of proteins involved in heme flux and function in resistant tumor cells Research Paper

The effectiveness of PD-1 inhibitors in non-small cell lung cancer (NSCLC) patients of different ages Research Paper

Newly developed anti-angiogenic therapy in non-small cell lung cancer Review

Comparative outcome assessment of epidermal growth factor receptor tyrosine kinase inhibitors for the treatment of advanced non-small-cell lung cancer: a network meta-analysis Meta-Analysis

Apatinib as a third- or further- line treatment in patients with advanced NSCLC harboring wild-type EGFR Clinical Research Papers

Implications of KRAS mutations in acquired resistance to treatment in NSCLC Review

Anti-PD-1/PD-L1 antibodies versus docetaxel in patients with previously treated non-small-cell lung cancer Meta-Analysis

Correlation among genetic variations of c-MET in Chinese patients with non-small cell lung cancer Research Paper

Downregulation of long non-coding RNA LET predicts poor prognosis and increases Notch signaling in non-small cell lung cancer Research Paper

HLA class I loss and PD-L1 expression in lung cancer: impact on T-cell infiltration and immune escape Research Paper